Chemicals classified as PRR23A3 Inhibitors are not directly inhibiting PRR23A3 but can influence the biological processes and signaling pathways that might intersect with the functional landscape of PRR23A3. Given the role of protein kinases in signal transduction and regulation of a myriad of cellular processes, inhibitors like Genistein, LY294002, and PD98059 can modify the activity of various kinases, thereby altering signaling pathways that PRR23A3 may be part of. These changes in kinase activity can lead to modified transcriptional programs and cellular responses, potentially impacting the function of PRR23A3.
Further, the intricacies of cell signaling involve multiple layers of regulation. Compounds such as Rapamycin and Y-27632 target key components of growth and cytoskeletal organization pathways, respectively, which are fundamental to cell function and behavior. By altering these pathways, the chemicals can indirectly influence the functional context within which PRR23A3 operates. Additionally, pathway-specific inhibitors like IWP-2, DAPT, Cyclopamine, and XAV939 target the production or activity of signaling molecules within the Wnt, Notch, and Hedgehog pathways, respectively.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Inhibits tyrosine kinases and can alter cellular signaling pathways, potentially affecting PRR23A3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, which is involved in a variety of signaling pathways, potentially affecting PRR23A3. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which can alter the MAPK/ERK pathway, potentially affecting PRR23A3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can alter AP-1 transcription factor activity, potentially affecting PRR23A3. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, potentially affecting stress response pathways linked to PRR23A3. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, potentially affecting the MAPK/ERK pathway and thereby influencing PRR23A3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which can affect cell growth and proliferation pathways involving PRR23A3. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK, potentially affecting cytoskeletal organization and related processes involving PRR23A3. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
Inhibits Wnt production, potentially affecting Wnt signaling pathways involving PRR23A3. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
Inhibits gamma-secretase, potentially affecting Notch signaling pathways involving PRR23A3. |